JUL 31, 2018 8:25 PM PDT

Pill Approved For Endometriosis Treatment

WRITTEN BY: Nouran Amin

A first drug, by the name of Elagolix, to treat for endometriosis-related pain, has recently become approved by the US Food and Drug Administration. Endometriosis is caused by uterine tissue moving to another part of the body, usually around the pelvis. The pain, which affects one in ten young women, can cause severe pelvic discomfort during menstruation, sexual intercourse, or all the time. Currently, endometriosis-related pain is managed by common painkillers, contraceptives that work to lessen or block menstruation, or through injectable hormonal treatments. In many cases, women suffering from endometriosis do not benefit from these treatments because they either don’t work, produce unpleasant side-effects such as weight gain or moodiness, or administered for only short periods of time due to the effects of the treatment on bone density.

Fortunately, Elagolix may be taken for longer, but it does come with several side-effects. During a placebo-controlled clinical trial study that examined almost 900 women with moderate to severe endometriosis pain, Elagolix was seen to reduce menstrual pain in over 40 percent of affected women and non-menstrual pelvic pain in over 50 percent when taken orally as a once-daily pill. Elagolix was also seen to reduce average pain ratings during sexual intercourse. The science of Elagolix works by reducing estrogen, the hormone that drives endometriosis. It is believed that because Elagolix slightly reduces the estrogen levels, the drug can be taken for up to two years. On the other hand, injectable hormone treatments, which effectively lower estrogen more powerfully, can only be administered for 6 months because it causes bone loss.

The side-effects that come with taking Elagolix include hot flushes and headaches in about 20 percent of the patient’s examined in the clinical trial with nausea occurring in about 10 percent. “Despite these side-effects, any extra options for treating endometriosis are welcome,” says Elizabeth Farrell, a gynecologist at Jean Hailes, an Australian women’s health organization. Farrell believes that despite the effectiveness of Elagolix, it is unlikely that it will become a first-line treatment for patients. “The oral contraceptive pill or an IUD would probably still be the first thing you tried,” she says.

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
FEB 26, 2021
Microbiology
Good Bacteria Fights Bad Bacteria in a Clinical Trial
FEB 26, 2021
Good Bacteria Fights Bad Bacteria in a Clinical Trial
Eczema is a skin condition that causes a chronic, itchy rash. The most common form of the disorder, atopic dermatitis, i ...
FEB 24, 2021
Drug Discovery & Development
Novel Neurofeedback Technique Improves Symptoms of Depression and Psychosis
FEB 24, 2021
Novel Neurofeedback Technique Improves Symptoms of Depression and Psychosis
Researchers from the University of Rochester have found that real-time functional magnetic resonance imaging (fMRI) neur ...
APR 06, 2021
Infographics
Psychedelic Medicine 101
APR 06, 2021
Psychedelic Medicine 101
As clinical trials for psychedelics progress, interest in psychedelics is increasing among pharmaceutical firms, clinici ...
APR 17, 2021
Drug Discovery & Development
Nanofiber-Based Drug Treats Inflammation
APR 17, 2021
Nanofiber-Based Drug Treats Inflammation
Researchers at Duke University worked on creating a self-assembling nanomaterial-based drug that can help address damage ...
APR 21, 2021
Drug Discovery & Development
Dietary Supplement Successfully Treats Mice with Schizophrenia
APR 21, 2021
Dietary Supplement Successfully Treats Mice with Schizophrenia
Researchers from the University of Tokyo have found that betaine, a dietary supplement found in sugar beets, reduces beh ...
MAY 03, 2021
Drug Discovery & Development
Low Dose Radiation May Improve Symptoms of Alzheimer's
MAY 03, 2021
Low Dose Radiation May Improve Symptoms of Alzheimer's
While high doses of radiation are known to be harmful, low doses may be able to help the body protect and repair. And no ...
Loading Comments...